This research demonstrates ginsenoside rg2's effects on cognitive function in APP/PS1 mice, suggesting neuroinflammation is a target for Alzheimer's disease therapy.
Key Points
Ginsenoside rg2 improves cognitive function and mitigates alzheimer's disease pathology, demonstrating its potential as a therapeutic intervention.
In APP/PS1 mice, cognitive assessments revealed that ginsenoside rg2 enhanced learning and memory, correlated with reduced neuroinflammation.
The study employed behavioral assessments, brain tissue analyses, and gut microbiome comparisons to explore ginsenoside rg2's mechanisms of action.
These findings support the neuroprotective role of ginsenoside rg2, emphasizing its effectiveness in managing alzheimer's disease through anti-neuroinflammatory actions.